Is Ozempic Good for Losing Weight?

Last reviewed: June 21, 2026

Last updated: June 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic contains semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes that has shown significant weight loss benefits in large-scale clinical studies. Semaglutide works by mimicking a natural hormone that tells your brain you're satisfied, which can reduce calorie intake without extreme dietary restriction. PlexusDx provides access to compounded semaglutide formulations for weight management at $189/mo month-to-month, or from $149/mo on the 6-month plan.

How Semaglutide Supports Weight Loss Results

Semaglutide activates GLP-1 receptors in areas of the brain that regulate appetite and blood sugar, leading to decreased hunger and increased feelings of fullness after smaller meals. In the STEP clinical trial program, participants taking semaglutide lost an average of 15–18% of their body weight over 68 weeks, compared to 2–3% in the placebo group. This mechanism works differently than stimulant-based weight loss medications, as it targets the root cause of overeating rather than simply increasing energy expenditure.

The medication also slows gastric emptying, meaning food stays in your stomach longer, which extends satiety between meals. Many patients report natural changes in food preferences and reduced cravings for high-calorie foods within the first 2–4 weeks of treatment. These effects are dose-dependent and typically become more pronounced as your body adjusts to the medication over several weeks.

Clinical Evidence Behind Semaglutide for Weight Management

Multiple peer-reviewed studies confirm that semaglutide produces weight loss in people across a wide range of BMI categories and metabolic backgrounds. The STEP 1 trial involved over 1,900 adults with obesity or overweight with weight-related conditions, and participants on semaglutide experienced sustained weight reduction that was largely maintained during the one-year follow-up phase. Effectiveness appears consistent regardless of age or baseline fitness level, though individual results vary based on adherence, diet, and genetic factors.

Long-term safety monitoring across clinical trials shows that semaglutide is generally well-tolerated when prescribed appropriately. Common side effects are mild to moderate gastrointestinal effects that typically diminish after the first month, and serious adverse events remain rare in properly screened populations. PlexusDx's personalized approach includes genetic testing options to identify which patients may benefit most from GLP-1 therapy based on their peptide metabolism.

Compounded Semaglutide vs. Brand-Name Ozempic Pricing

Ozempic brand-name pens can cost $900 to $1,300 per month through traditional pharmacy channels, even with insurance coverage, due to high manufacturer pricing and specialty pharmacy markups. PlexusDx's compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan from licensed 503A compounding pharmacies, making the same active ingredient accessible to people who cannot afford branded versions. Your dose may need to go up during treatment titration, but your monthly price remains flat across all dose levels—a commitment PlexusDx maintains across its three membership tiers.

Compounded medications come from federally licensed 503A pharmacies that follow strict quality and sterility standards identical to those for brand-name injectables. PlexusDx serves all 50 states without requiring insurance coverage, membership fees, or prior authorization delays. HSA and FSA accounts are eligible, providing additional savings for qualified patients.

Genetic Testing to Personalize Your Semaglutide Response

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The genetic test costs $298, revealing 150+ personalized health insights. Understanding your genetic predisposition to GLP-1 sensitivity can help you set realistic weight loss goals and adjust expectations based on your individual physiology rather than population averages. PlexusDx clinicians use these results to refine medication choice, starting dose, and titration pace for optimal outcomes and tolerability.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Can I get semaglutide without an Ozempic prescription?

Yes. PlexusDx prescribes compounded semaglutide injections through licensed 503A pharmacies, offering the same active ingredient as Ozempic at a lower cost at $189/mo month-to-month, or from $149/mo on the 6-month plan. No insurance or prior authorization is required; you work directly with PlexusDx clinicians who evaluate your eligibility and health history.

How much weight do most people lose on semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Is compounded semaglutide as safe as brand-name Ozempic?

Compounded semaglutide from licensed 503A pharmacies meets the same FDA quality and sterility standards as brand products. PlexusDx uses only federally approved compounding pharmacies; 503B bulk facilities are not used. Safety profiles are comparable when prescribed by qualified clinicians with appropriate medical screening.

What are the most common side effects of semaglutide?

Nausea, vomiting, and constipation are the most frequently reported side effects, typically mild and temporary during the first 2–4 weeks as your body adjusts. More serious side effects such as pancreatitis or gallbladder issues are rare in properly screened patients. PlexusDx clinicians monitor for contraindications and provide guidance on managing gastrointestinal effects through diet and dose timing.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

PlexusDx's Precision Peptide Genetic Test identifies variants in GIPR genes that influence your semaglutide response and appetite regulation capacity. While genetics are not destiny, understanding your peptide-pathway profile helps clinicians personalize your starting dose, titration schedule, and compound choice—increasing your odds of sustained weight loss with fewer side effects.

Related Reading

• Ozempic For Losing Weight
• Glp 1 For Losing Weight
• Zepbound For Losing Weight
• Mounjaro For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.